Company news
Thiogenesis Therapeutics Corp news in 2024
Thiogenesis Therapeutics Corp's news releases, calls and decks from 2024, newest first.
Thiogenesis Announces Presentation on UMDF Webcast Featuring Clinical Trials in Mitochondrial Disease
December 10, 2024
Thiogenesis Announces DTC Eligibility in the U.S. and Other Updates
November 28, 2024
Thiogenesis Announces Important Core Patent Allowed in Europe
November 4, 2024
Thiogenesis Announces Investor Relations Engagement
September 27, 2024
Thiogenesis Announces Presentation at 3rd Annual Leigh Syndrome Symposium
September 17, 2024
Thiogenesis Announces Collaboration and Updates on Pediatric NASH Clinical Program
August 20, 2024
Thiogenesis Announces Leigh Syndrome Clinical Program
July 18, 2024
Thiogenesis Announces Acceptance of Clinical Trial Application - Part I in the EU for MELAS
March 25, 2024